Koninklijke Philips traded at $27.11 this Thursday April 2nd, decreasing $0.18 or 0.66 percent since the previous trading session. Looking back, over the last four weeks, Koninklijke Philips lost 10.65 percent. Over the last 12 months, its price rose by 13.62 percent. Looking ahead, we forecast Koninklijke Philips to be priced at 26.69 by the end of this quarter and at 24.68 in one year, according to Trading Economics global macro models projections and analysts expectations.
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.